137 related articles for article (PubMed ID: 22928662)
21. Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema.
Varga L; Füst G; Csuka D; Farkas H
Mol Immunol; 2011 Jan; 48(4):572-6. PubMed ID: 21111483
[TBL] [Abstract][Full Text] [Related]
22. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.
van Doorn MB; Burggraaf J; van Dam T; Eerenberg A; Levi M; Hack CE; Schoemaker RC; Cohen AF; Nuijens J
J Allergy Clin Immunol; 2005 Oct; 116(4):876-83. PubMed ID: 16210064
[TBL] [Abstract][Full Text] [Related]
23. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
Schneider L; Hurewitz D; Wasserman R; Obtulowicz K; Machnig T; Moldovan D; Reshef A; Craig TJ
Pediatr Allergy Immunol; 2013 Feb; 24(1):54-60. PubMed ID: 23173714
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of recombinant human C1 inhibitor in patients with hereditary angioedema.
Farrell C; Hayes S; Relan A; van Amersfoort ES; Pijpstra R; Hack CE
Br J Clin Pharmacol; 2013 Dec; 76(6):897-907. PubMed ID: 23594263
[TBL] [Abstract][Full Text] [Related]
25. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.
Riedl MA; Lumry WR; Li HH; Banerji A; Bernstein JA; Ba M; Bjrkander J; Magerl M; Maurer M; Rockich K; Chen H; Schranz J
Allergy Asthma Proc; 2016 Nov; 37(6):489-500. PubMed ID: 27931305
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
[TBL] [Abstract][Full Text] [Related]
28. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
[TBL] [Abstract][Full Text] [Related]
29. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein levels in hereditary angioedema.
Hofman ZL; Relan A; Hack CE
Clin Exp Immunol; 2014 Jul; 177(1):280-6. PubMed ID: 24588117
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
Riedl MA; Li HH; Cicardi M; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805
[TBL] [Abstract][Full Text] [Related]
32. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
33. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.
Zuraw BL; Busse PJ; White M; Jacobs J; Lumry W; Baker J; Craig T; Grant JA; Hurewitz D; Bielory L; Cartwright WE; Koleilat M; Ryan W; Schaefer O; Manning M; Patel P; Bernstein JA; Friedman RA; Wilkinson R; Tanner D; Kohler G; Gunther G; Levy R; McClellan J; Redhead J; Guss D; Heyman E; Blumenstein BA; Kalfus I; Frank MM
N Engl J Med; 2010 Aug; 363(6):513-22. PubMed ID: 20818886
[TBL] [Abstract][Full Text] [Related]
34. Assessment of hereditary angioedema treatment risks.
Kalaria S; Craig T
Allergy Asthma Proc; 2013; 34(6):519-22. PubMed ID: 24169059
[TBL] [Abstract][Full Text] [Related]
35. New treatment options for acute edema attacks caused by hereditary angioedema.
Thomas MC; Shah S
Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
[TBL] [Abstract][Full Text] [Related]
36. Hereditary Angioedema Attacks: Local Swelling at Multiple Sites.
Hofman ZL; Relan A; Hack CE
Clin Rev Allergy Immunol; 2016 Feb; 50(1):34-40. PubMed ID: 25527240
[TBL] [Abstract][Full Text] [Related]
37. C1-esterase inhibitor (Cinryze
Gupta R; Balduzzi J; Davis-Lorton M
Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
[TBL] [Abstract][Full Text] [Related]
38. [Hereditary angioedema. Treatment of acute attacks in Argentina].
Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
[TBL] [Abstract][Full Text] [Related]
39. Clinical impact of peripheral attacks in hereditary angioedema patients.
Kusuma A; Relan A; Knulst AC; Moldovan D; Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Hack CE
Am J Med; 2012 Sep; 125(9):937.e17-24. PubMed ID: 22748405
[TBL] [Abstract][Full Text] [Related]
40. Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits.
van Veen HA; Koiter J; Vogelezang CJ; van Wessel N; van Dam T; Velterop I; van Houdt K; Kupers L; Horbach D; Salaheddine M; Nuijens JH; Mannesse ML
J Biotechnol; 2012 Dec; 162(2-3):319-26. PubMed ID: 22995741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
